Opioid-free anesthesia with dexmedetomidine, lidocaine and propofol infusions may be an alternative technique for laparoscopic cholecystectomy especially in patients with high risk for postoperative nausea and vomiting.

SUMMARY:The BPL is a part of the peripheral nervous system. Many disease processes affect the BPL. In this article, on the basis of 60 patients, we reviewed MR imaging findings of subjects with brachial plexopathy. Different varieties of BPL lesions are discussed.ABBREVIATIONS: AA ϭ axillary artery; ABD ϭ abduction; ADs ϭ anterior divisions; AS ϭ anterior scalene muscle; AV ϭ axillary vein; BPL ϭ brachial plexus; CC ϭ costoclavicular space; CL ϭ clavicula; EMG, electromyelography; I ϭ inferior trunk; IS ϭ interscalene triangular space; LC ϭ lateral cord; M ϭ middle trunk; MC ϭ medial cord; MRA ϭ MR angiography; MRV ϭ MR venography; MS ϭ middle scalene; NEU ϭ neutral; PC ϭ posterior cord; PDs ϭ posterior divisions; PET ϭ positron-emission tomography; PMA ϭ pectoralis major muscle; PMI ϭ pectoralis minor muscle; RP ϭ retropectoralis minor space; S ϭ superior trunk; SA ϭ subclavian artery; STIR ϭ short tau inversion recovery; SV ϭ subclavian vein; T1WI ϭ T1-weighted imaging; T2WI ϭ T2-weighted imaging; TOS ϭ thoracic outlet syndrome; TSE ϭ turbo spin-echo M any disease processes affect the BPL, and the common lesions can vary according to the age of subjects. In neonates and adolescents, traumatic injury is common. In middle-aged and older individuals, intrinsic and extrinsic tumors of the BPL, cervical spondylosis, TOS, and inflammatory plexopathy (idiopathic, infectious, radiation-induced, immunemediated, and toxic) are common. On the basis of 60 patients, we reviewed MR imaging findings of subjects with brachial plexopathy. Different varieties of BPL lesions and imaging techniques are discussed. Anatomy of the BPLThe BPL is a part of the peripheral nervous system, responsible for innervation of the shoulder, upper extremity and upper chest muscles, and cutaneous nerves of the skin and hand, with branches to the phrenic nerve (C3-C5) for diaphragm movement and to the sympathetic ganglia via the C8 and T1 nerves. In the cervicothoracobrachial region, the BPL courses superior and posterior to the subclavian artery and vein. The subclavian vein is located at the most anterior extent, anteroinferior to the anterior scalene muscle. The subclavian artery extends along the floor of the interscalene triangle between the anterior and middle scalene muscles. The BPL has 5 segments: roots, trunks, divisions, cords, and terminal branches. The supraclavicular plexus includes roots and trunks. Through the neural foramina, roots of the BPL extend into the interscalene region, forming the superior (C5 and C6), middle (C7), and inferior (C8 and T1) trunks at the lateral border of middle scalene muscles. The retroclavicular plexus is located in the costoclavicular space, posterior to the clavicle and above the subclavian artery and vein, including the anterior and posterior division of the trunks. The infraclavicular plexus is situated in the retropectoralis minor space, lateral to the first rib, posterior to pectoralis muscles, and above the axillary artery and vein, including the 3 (medial, lateral, and posterior) cords and term...

To recognize the period of exaggerated cytokine response in patients with coronavirus disease 2019 (COVID-19) pneumonia, and to describe the clinical outcomes of using tocilizumab as a treatment option. The data of 12 adult COVID-19 pneumonia patients who were followed in the inpatient clinics of Biruni University Medical Faculty Hospital (Istanbul, Turkey) were retrospectively analyzed. Diagnostic tests, laboratory examinations, clinical findings, and computed tomography of the thorax imaging results were evaluated. A dramatic laboratory and clinical improvement was observed in 83% (10 out of 12) of patients after tocilizumab. In 17% (2 out of 12) of our patients, short-term ventilator support was required in the intensive care unit. The longest hospital stay was 18 days. However, in the end, all of our patients were discharged home with good health. Although arterial oxygen saturations (87.58 ± 3.12%) dropped in room air in the pretocilizumab period, post-tocilizumab they normalized in all patients (94.42 ± 1%). None of them had fever after tocilizumab treatment and the levels of C-reactive protein (13.08 ± 12.89) were almost within normal limits. Eosinophil values were quite low at the time of diagnosis (10 ± 17.06), but increased significantly post-tocilizumab (155.33 ± 192.69). There is currently no proven treatment for COVID-19 induced by novel coronavirus SARS-CoV-2. Based on our experience with twelve adult COVID-19 pneumonia patients, we can say that tocilizumab, an IL-6 inhibitor, is more beneficial in preventing the damage caused by excessive cytokine response in the body if administered at the right time and provides clinical and radiological recovery.

Opioid-free anesthesia with dexmedetomidine, lidocaine and propofol infusions may be an alternative technique for laparoscopic cholecystectomy especially in patients with high risk for postoperative nausea and vomiting.

In this study, we report a large family cluster consisting of 29 genetically related patients hospitalized with coronavirus disease-2019 (COVID-19). We sought to determine the clinical characteristics relevant to the clinical course of COVID-19 by comparing the family cluster to unrelated patients with SARS-CoV-2 infection so that the presence of potential determinants of disease severity, other than traditional risk factors previously reported, could be investigated. Twenty-nine patient files were investigated in group 1 and group 2 was created with 52 consecutive patients with COVID-19 having age and gender compatibility. The virus was detected for diagnosis. The clinical, laboratory and imaging features of all patients were retrospectively screened. Disease course was assessed using records regarding outcome from patient files retrospectively. Groups were compared with respect to baseline characteristics, disease severity on presentation, and disease course. There was no difference between the two groups in terms of comorbidity and smoking history. In terms of inhospital treatment, use differed not significantly between two groups. We found that all 29 patients in the group 1 had severe pneumonia, 18 patients had severe pneumonia. Hospitalization rates, length of hospital stay, and transferred to intensive care unit were found to be statistically significantly higher in the group 1. In the present study, COVID-19 cases in the large family cluster were shown to have more severe disease and worse clinical course compared with consecutive patients with COVID-19 presenting to the same time. We believe further studies into potential genetic mechanisms of host susceptibility to COVID-19 should include such family clusters.

No abstract

Objectives: This study aimed to evaluate the effect of preoperative sphenopalatine ganglion block (SPBG) on the postoperative pain (POP) in patients undergoing septorhinoplasty (SRP). Methods: A retrospective cohort study was performed. A total of 42 patients that had received septorhinoplasty included in the study. The patients that had received SPBG before the surgery included in the Block group (n:20) and the patients that had not received SPBG before the surgery included in the Control group (n:22). POP was questioned with a numeric rating scale (NRS) at the 30th minute (t1), 1st hour (t2), 4th hour (t3), 12th hour (t4), and 24th hour (t5) and noted. The intraoperative details and the dose of the postoperative rescue analgesics were also noted. Results: The average dose of Paracetamol that was used in the postoperative first 24 hours was 500 mg in the Block group and 1363 mg in the Control group, and the difference was statistically significant ( P = .001). The average dose of Tramadol was 0 mg in the Block group and 45 mg in the Control group, and the difference was statistically significant ( P = .001). There was a statistically significant difference among the groups with respect to NRS in the first 24 hours postoperatively ( P < .05). The number of the patients requiring rescue analgesics was lower in the Block group than the Control group. The difference was statistically significant at the t1, t2, and t5 time intervals ( P > .05). Conclusions: Preoperative SPGB is an effective option to reduce POP and the need for rescue analgesics for patients undergoing SRP. Clinical trial number: NCT04020393

Application of total intravenous anesthesia (TIVA) may be considered as unpractical when compared with inhalational anesthesia. Although it is mostly not recommended, mixing intravenous agents is popular in clinical practice. The aim of the present study was to investigate the suitability of using remifentanil-propofol mixture (MIXTIVA) for TIVA. Adult patients with an American Society of Anesthesiologists grade of I-II scheduled for elective thyroidectomy were randomly allocated to 3 groups (n=32 for each) to receive TIVA with remifentanil and propofol infusions separately (control group, Group I) or with MIXTIVA infusion that contained remifentanil/propofol at a proportion of 2/1,000 or 3/1,000 (remifentanil concentration, 20 or 30 µg/ml in 1% propofol in Group II or Group III, respectively). The extubation time (the primary outcome of the study), the orientation time and number of patients in whom intraoperative hypotension, hypertension or bradycardia episodes were encountered during anesthesia were comparable among the groups. The mean remifentanil infusion rate in Group III was significantly higher than that in the other groups. The mean propofol infusion rates and mean bispectral index (BIS) scores during anesthesia were comparable among groups. Hypotension accompanied with a high BIS was encountered in one patient in Group III. In conclusion, compared to the standard TIVA technique using separate drug infusions, MIXTIVA infusion used for thyroidectomies did not result in any statistically significant difference in recovery and clinical outcomes. This technique may be considered as a practical implementation for busy ambulatory centers performing general anesthesia. The present study was retrospectively registered at clinicaltrials. gov (trial registration no. NCT04394897).